Amidst of COVID-19 outbreak, Infinium wishes to extend its support to the industry by offering 30% discount on its market research reports across all license formats.
Request Discount
Loading...
COVID-19! We are now including the impact analysis of the COVID-19 on Anti-rheumatics Market report and the forecast period of this report shall be revised to 2020-2026. The section on the impact of COVID-19 on this market is included in the report for free. To know more Request a Sample of this report.

Anti-rheumatics Market (Drug Class - Disease Modifying Anti-rheumatics Drugs (DMARD'S), Nonsteroidal Anti-inflammatory Drugs (NSAID'S), Corticosteroids, Uric Acid Drugs, and Others; Type - Prescription-based Drugs, and Over-the-counter Drugs; End User - Hospitals & Clinics, Ambulatory Surgical Centers, and Healthcare Specialty Process; Distribution Channel - Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : March, 2020

  • Rep Id : HC0841

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the anti-rheumatics market provides an in-depth analysis of segments and sub-segments in the global as well as regional anti-rheumatics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional anti-rheumatics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global anti-rheumatics market. According to the report, the global anti-rheumatics market is projected to grow at a CAGR of 9.5% over the forecast period of 2019-2025.

 

Segment Covered

The report on global anti-rheumatics market covers segments such as drug class, type, end user, and distribution channel. On the basis of drug class, the sub-markets include disease modifying anti-rheumatics drugs (DMARD'S), nonsteroidal anti-inflammatory drugs (NSAID'S), corticosteroids, uric acid drugs, and others. On the basis of type, the sub-markets include prescription-based drugs, and over-the-counter drugs. On the basis of end user, the sub-markets include hospitals & clinics, ambulatory surgical centers, and healthcare specialty process. On the basis of distribution channel, the sub-markets include retail pharmacies, online pharmacies, and hospital pharmacies.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer, Inc., Johnson & Johnsons, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Celegene Corporations, MedImmune, LLC, Takeda Pharmaceutical Company Ltd., Biogen Inc., Celltrion Inc., and Amgen Inc.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of anti-rheumatics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount